Drugs / TALL-104
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00415909 | Dec 2006 → May 2013 | chronic myeloid leukemia | M.D. Anderson Cancer Center | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TALL-104 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00415909 ↗ |
| Route | Intravenous | “TALL-104 cells will be given intravenously over 1 hour” NCT00415909 ↗ |